TP53 and cancer: Additionally, other constitutively active AKT1 mutants (AKT1-308D-473D, myr-AKT1) apparently induce pre-neoplastic lesions and have been shown to require additional events, such as a loss of Tp53 or chemical carcinogens to progress to fully malignant tumors [48,51].